Creative:
ENHERTU is indicated for the treatment of multiple HER2-expressing tumor types. I worked on the HCP side of this account, which was a lot like an agency within an agency (it was the only brand I worked on at FCB). Most of the indications I worked on were in the breast category, but I also helped out other indications from time to time. In addition to the sampling of projects below, I worked on a lot of social media, digital display, and convention assets.
HER2+ CVA
The constantly updating flagship piece of the main indication I touched (HER2+ metastatic breast cancer [mBC]). I was mostly involved in the fact check process of this document.
HCP Website
I was involved in constant upkeep of the ENHERTU HCP Website, which involved a lot of critical thinking about the user experience and story flow when it came to presentation of the data.
Health-Related Quality of Life Reprint Carrier
A print piece that gave an abridged summary of a full Annals of Oncology article reprint, included within the carrier itself. I mostly led the creation of the project.
Agency:
FCB Health NY
Copy:
Alex Basa
Joe Catanzaro
Brittany Maulen
Nonso Onwumah
Art:
Too many to list, honestly…